Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Batavia › NPI 1902800352
Clinic

United Memorial Medical Center

United Memorial Medical Center was paid $25.45M by Medicaid between Jan 2018 and Dec 2024, across 266 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 15% of everything it billed.

33Billing provider infoUNITED MEMORIAL MEDICAL CENTER
BATAVIA, NY 14020
33aNPI1902800352assigned 06/13/2005
28Total paid$25.45M
24GClaims508,901
24DCodes billed266
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Urgent Care Clinic/Center providers in New York

Rank by total paid#9 of 138
Median peer was paid$576K
This provider vs. median44×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018569$85K
201922,401$997K
202071,379$3.27M
202194,853$4.71M
2022108,590$5.51M
2023117,447$5.91M
2024incomplete93,662$4.96M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 15% 37,661 32,351 $3.87M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 9.1% 22,982 21,043 $2.32M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 6.9% 12,192 11,666 $1.75M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.5% 9,385 8,525 $1.39M
96361 Intravenous infusion, hydration; each additional hour 5.4% 6,500 5,726 $1.38M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 5.0% 9,433 8,615 $1.28M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.9% 913 907 $729K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.6% 2,123 2,097 $671K
41899 Unlisted procedure, dentoalveolar structures 2.3% 301 300 $580K
70450 Computed tomography, head or brain; without contrast material 1.9% 1,635 1,595 $477K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.7% 1,343 1,324 $423K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 3,072 3,016 $421K
254 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.6% 9,028 $415K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.5% 478 $394K
80053 Comprehensive metabolic panel 1.5% 26,234 $387K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.5% 2,838 $384K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.4% 1,221 $345K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.3% 1,903 $341K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.3% 853 $329K
59025 Fetal non-stress test 1.2% 1,931 $317K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.1% 2,411 $273K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.0% 6,017 $267K
87631 1.0% 3,275 $259K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.0% 4,347 $256K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 3,440 $252K
20610 <1% 973 $220K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 698 $215K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,306 $208K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 6,667 $204K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,658 $170K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 1,684 $169K
93975 <1% 632 $162K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 6,682 $158K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 187 $156K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 2,184 $153K
71275 Computed tomographic angiography, chest, with contrast material <1% 420 $137K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 5,721 $136K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,786 $128K
99215 Doctor's office visit, returning patient (complex) <1% 1,178 $126K
97161 <1% 1,297 $108K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,225 $105K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,822 $101K
76801 <1% 1,124 $101K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 1,048 $98K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 466 $97K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,157 $96K
71046 Radiologic examination, chest; 2 views <1% 2,855 $89K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 24,080 $85K
36415 Collection of venous blood by venipuncture <1% 28,569 $83K
84443 Thyroid stimulating hormone (TSH) <1% 9,683 $82K
80048 Basic metabolic panel (calcium, ionized) <1% 5,658 $78K
80061 Lipid panel <1% 9,249 $77K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 6,263 $67K
76830 Ultrasound, transvaginal <1% 485 $65K
74018 <1% 1,244 $58K
73564 <1% 1,159 $57K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 520 $55K
76770 <1% 296 $55K
83036 Hemoglobin; glycosylated (A1C) <1% 7,327 $53K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 3,292 $51K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 490 $49K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 1,024 $47K
73610 <1% 1,339 $46K
87660 <1% 4,476 $44K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 435 $44K
87634 <1% 1,343 $44K
90715 <1% 1,589 $44K
73030 <1% 1,051 $42K
73630 <1% 1,257 $40K
84702 <1% 5,159 $37K
87480 <1% 4,252 $37K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 326 $36K
87510 <1% 4,209 $36K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 70 $36K
96375 Therapeutic injection; each additional sequential IV push <1% 4,972 $35K
84484 <1% 6,795 $35K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 40 $34K
86850 <1% 2,022 $33K
76536 <1% 279 $33K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 734 $33K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,282 $33K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 342 $32K
73100 <1% 663 $30K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 4,741 $29K
84439 <1% 3,759 $27K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 12 $27K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 232 $26K
82607 <1% 2,544 $26K
90686 <1% 1,122 $25K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,157 $24K
82728 <1% 2,341 $23K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 118 $22K
86780 <1% 2,297 $22K
86803 <1% 2,588 $22K
99203 Doctor's office visit, new patient (routine) <1% 225 $22K
87150 <1% 753 $22K
86900 <1% 1,958 $21K
73502 <1% 481 $20K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 226 $19K
81025 <1% 4,315 $19K
86901 <1% 1,967 $19K
83655 <1% 1,500 $17K
83690 <1% 5,480 $17K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,495 $17K
85027 <1% 5,000 $17K
83880 <1% 566 $16K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 107 $16K
87070 <1% 2,267 $16K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 280 $14K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 26 $14K
71045 Radiologic examination, chest; single view <1% 2,123 $14K
87340 <1% 1,751 $13K
73130 <1% 426 $13K
86762 <1% 1,085 $12K
96376 <1% 729 $12K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 27 $12K
83550 <1% 2,388 $11K
83735 <1% 3,245 $11K
85610 <1% 3,059 $11K
90677 <1% 251 $11K
83540 <1% 2,571 $11K
87081 <1% 2,824 $10K
87040 <1% 2,237 $10K
87186 <1% 1,920 $9K
72100 <1% 163 $9K
84403 <1% 403 $9K
81001 <1% 5,192 $9K
93971 <1% 72 $8K
73560 <1% 296 $8K
76813 <1% 120 $8K
73110 <1% 253 $8K
82784 <1% 648 $7K
83605 <1% 1,616 $7K
82570 <1% 1,889 $7K
G0378 Hospital observation service, per hour <1% 112 $7K
87077 <1% 1,270 $7K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 53 $7K
80076 <1% 870 $7K
82803 <1% 238 $7K
73140 <1% 217 $7K
82746 <1% 694 $6K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 494 $6K
82043 <1% 1,458 $6K
86140 <1% 1,881 $6K
88142 <1% 245 $6K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 549 $6K
76641 <1% 24 $5K
73120 <1% 122 $5K
84153 <1% 401 $5K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 43 $5K
99385 <1% 56 $5K
85379 <1% 1,028 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 563 $4K
81003 <1% 4,149 $4K
87430 <1% 826 $4K
87088 <1% 756 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,168 $4K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 536 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,362 $4K
99204 Doctor's office visit, new patient (more involved) <1% 36 $4K
85730 <1% 1,197 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 25 $4K
90651 <1% 73 $4K
86706 <1% 468 $4K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 188 $4K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $4K
97162 <1% 40 $4K
90656 <1% 172 $4K
86038 <1% 578 $3K
84402 <1% 149 $3K
85652 <1% 1,982 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 56 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 724 $3K
84481 <1% 278 $3K
J0690 Injection, cefazolin sodium, 500 mg <1% 494 $3K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 363 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 679 $3K
G0008 Administration of influenza virus vaccine <1% 187 $2K
86704 <1% 262 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 78 $2K
86376 <1% 166 $2K
82950 <1% 526 $2K
73080 <1% 34 $2K
83970 <1% 52 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 77 $2K
83001 <1% 125 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,794 $2K
84480 <1% 271 $2K
87641 <1% 66 $2K
99442 <1% 159 $2K
88342 <1% 12 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,767 $2K
90680 <1% 56 $1K
73590 <1% 32 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,021 $1K
86481 <1% 24 $1K
82550 <1% 378 $1K
99239 Hospital discharge day management, more than 30 minutes <1% 14 $1K
83002 <1% 76 $1K
99173 <1% 595 $1K
86696 <1% 83 $1K
84550 <1% 338 $1K
72110 <1% 24 $1K
90697 <1% 38 $996.94
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 1,088 $990.77
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,661 $947.79
86141 <1% 95 $911.00
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 39 $883.58
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 118 $874.63
83520 <1% 112 $843.22
87147 <1% 359 $810.88
86431 <1% 201 $810.15
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 89 $803.81
81002 <1% 1,164 $747.41
84703 <1% 212 $746.86
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 354 $726.53
90734 <1% 56 $702.80
84146 <1% 40 $702.28
87522 Neg quan hep c or qual rna <1% 12 $660.96
87205 <1% 280 $652.39
90633 <1% 30 $627.50
99441 <1% 79 $586.24
82947 <1% 310 $533.04
84100 <1% 162 $511.34
88304 <1% 16 $508.42
86308 <1% 193 $481.76
97010 <1% 41 $476.90
96161 <1% 12 $475.44
80305 <1% 527 $420.11
83525 <1% 43 $412.16
86705 <1% 49 $400.08
86618 <1% 36 $390.53
84436 <1% 67 $363.41
J2270 Injection, morphine sulfate, up to 10 mg <1% 992 $359.51
86800 <1% 25 $311.06
J7050 Infusion, normal saline solution, 250 cc <1% 97 $310.04
90619 <1% 15 $301.20
80074 <1% 13 $293.37
86709 <1% 59 $281.33
86592 <1% 55 $182.45
82248 <1% 43 $179.07
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 62 $160.41
82150 <1% 65 $157.48
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 26 $134.16
83993 <1% 12 $125.55
99443 <1% 15 $120.56
83615 <1% 26 $111.55
86765 <1% 12 $109.72
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 560 $105.88
87449 <1% 24 $105.54
87272 <1% 12 $102.06
96127 <1% 17 $75.85
73562 <1% 12 $75.00
J2550 Injection, promethazine hcl, up to 50 mg <1% 198 $69.46
84156 <1% 31 $61.79
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 64 $39.18
90472 Immunization administration, each additional vaccine (list separately) <1% 72 $35.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 112 $29.50
85018 <1% 25 $26.67
J1630 Injection, haloperidol, up to 5 mg <1% 12 $4.83
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 18 $3.56
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 17 $2.87
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 67 $0.36
99177 0% 25 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 109 $0.00
A9270 Non-covered item or service 0% 575 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGLASTONBURY, HOWARD (CFO)